Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(1R,2S,3S,4R,5R)-5-(4-Chloro-3-(4-ethoxybenzyl)phenyl-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol is an ertugliflozin impurity with potential research applications, Ertugliflozin (CAS: 1210344-57-2) is explored for long term efficacy and safety for treatment of type-2 diabetes.